Pharmaceutical compositions for treating viral, proliferative and
inflammatory diseases are disclosed comprising an amount of pharmaceutically acceptable
vitamin B12 compound in combination with an interferon compound. Vitamin B12 compounds
are administered separately, simultaneously or in combination with interferon compounds
to provide an enhanced therapeutic effect for treating viral, proliferative and
inflammatory diseases.
